Zurcher Kantonalbank (Zurich Cantonalbank) Pep Gen Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$3.86 - $7.96 $5,056 - $10,427	-1,310 Reduced 99.92%	1 $0
Q3 2023 Oct 25, 2023	SELL	$5.0 - $9.09 $1,045 - $1,899	-209 Reduced 13.75%	1,311 $6,000
Q2 2023 Aug 07, 2023	SELL	$8.94 - $16.39 $3,397 - $6,228	-380 Reduced 20.0%	1,520 $13,000
Q1 2023 May 08, 2023	BUY	$11.44 - $17.7 $21,736 - $33,630	1,900 New	1,900 $23,000

Others Institutions Holding PEPG

# of Institutions

Shares Held

25.2M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

10.7M
Shares

$15.4 Million
1.27% of portfolio
Janus Henderson Group PLC London, X0

2.34M
Shares

$3.36 Million
0.01% of portfolio
Suvretta Capital Management, LLC New York, NY

1.66M
Shares

$2.39 Million
0.56% of portfolio
Viking Global Investors LP

1.48M
Shares

$2.13 Million
0.05% of portfolio
Perceptive Advisors LLC New York, NY

1.41M
Shares

$2.03 Million
0.32% of portfolio

View Full List

About PepGen Inc.

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $34M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

More about PEPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account